(Q34580311)

English

Activation of MAPK in hearts of EMD null mice: similarities between mouse models of X-linked and autosomal dominant Emery Dreifuss muscular dystrophy

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Activation of MAPK in hearts of EMD null mice: similarities between mouse models of X-linked and autosomal dominant Emery Dreifuss muscular dystrophy (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

object named as

Antoine Muchir

1

0 references

object named as

Paul Pavlidis

2

0 references

object named as

Gisèle Bonne

3

0 references

author name string

Yukiko K Hayashi

4

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Howard J Worman

5

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

publication date

13 June 2007

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Human Molecular Genetics

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

16

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

15

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

1884-1895

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Emery-Dreifuss muscular dystrophy - a 40 year retrospective

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM137

21 January 2018

Identification of a novel X-linked gene responsible for Emery-Dreifuss muscular dystrophy

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM137

21 January 2018

Emerin deficiency at the nuclear membrane in patients with Emery-Dreifuss muscular dystrophy

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM137

21 January 2018

The Emery-Dreifuss muscular dystrophy protein, emerin, is a nuclear membrane protein

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM137

21 January 2018

Heart-specific localization of emerin: new insights into Emery-Dreifuss muscular dystrophy

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM137

21 January 2018

Multiple and surprising new functions for emerin, a nuclear membrane protein

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM137

21 January 2018

The inner nuclear membrane protein emerin regulates beta-catenin activity by restricting its accumulation in the nucleus

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM137

21 January 2018

Mutations in the gene encoding lamin A/C cause autosomal dominant Emery-Dreifuss muscular dystrophy

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM137

21 January 2018

Homologies in both primary and secondary structure between nuclear envelope and intermediate filament proteins

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM137

21 January 2018

cDNA sequencing of nuclear lamins A and C reveals primary and secondary structural homology to intermediate filament proteins

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM137

21 January 2018

Keratin-like proteins that coisolate with intermediate filaments of BHK-21 cells are nuclear lamins

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM137

21 January 2018

Essential roles for Caenorhabditis elegans lamin gene in nuclear organization, cell cycle progression, and spatial organization of nuclear pore complexes

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM137

21 January 2018

Nuclear envelope alterations in fibroblasts from LGMD1B patients carrying nonsense Y259X heterozygous or homozygous mutation in lamin A/C gene

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM137

21 January 2018

Disruption of nuclear lamin organization alters the distribution of replication factors and inhibits DNA synthesis

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM137

21 January 2018

Disruption of nuclear lamin organization blocks the elongation phase of DNA replication

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM137

21 January 2018

Alteration of nuclear lamin organization inhibits RNA polymerase II-dependent transcription

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM137

21 January 2018

The inner nuclear membrane

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM137

21 January 2018

Direct interaction between emerin and lamin A

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM137

21 January 2018

Interaction between emerin and nuclear lamins

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM137

21 January 2018

The nuclear envelope and human disease

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM137

21 January 2018

Loss of A-type lamin expression compromises nuclear envelope integrity leading to muscular dystrophy

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM137

21 January 2018

Expression of an LMNA-N195K variant of A-type lamins results in cardiac conduction defects and death in mice.

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM137

21 January 2018

Loss of emerin at the nuclear envelope disrupts the Rb1/E2F and MyoD pathways during muscle regeneration.

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM137

21 January 2018

Emerin-lacking mice show minimal motor and cardiac dysfunctions with nuclear-associated vacuoles

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM137

21 January 2018

Activation of MAPK pathways links LMNA mutations to cardiomyopathy in Emery-Dreifuss muscular dystrophy

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM137

21 January 2018

c-Jun N-terminal kinase activation mediates downregulation of connexin43 in cardiomyocytes

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM137

21 January 2018

Genetic causes of human heart failure

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM137

21 January 2018

Altered intracellular Ca2+ handling in heart failure

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM137

21 January 2018

Evaluation of methods for oligonucleotide array data via quantitative real-time PCR

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM137

21 January 2018

How to decide? Different methods of calculating gene expression from short oligonucleotide array data will give different results

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM137

21 January 2018

Mitogen-activated protein kinases in the heart

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM137

21 January 2018

Redefining the roles of p38 and JNK signaling in cardiac hypertrophy: dichotomy between cultured myocytes and animal models

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM137

21 January 2018

Targeted inhibition of p38 MAPK promotes hypertrophic cardiomyopathy through upregulation of calcineurin-NFAT signaling

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM137

21 January 2018

Activated MEK5 induces serial assembly of sarcomeres and eccentric cardiac hypertrophy.

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM137

21 January 2018

The MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM137

21 January 2018

Caveolin-3 knock-out mice develop a progressive cardiomyopathy and show hyperactivation of the p42/44 MAPK cascade

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM137

21 January 2018

Caveolin-1 null mice develop cardiac hypertrophy with hyperactivation of p42/44 MAP kinase in cardiac fibroblasts

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM137

21 January 2018

Class IA phosphoinositide 3-kinase regulates heart size and physiological cardiac hypertrophy

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM137

21 January 2018

Germline mutations in genes within the MAPK pathway cause cardio-facio-cutaneous syndrome

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM137

21 January 2018

Differential Activation of Signal Transduction Pathways in Human Hearts With Hypertrophy Versus Advanced Heart Failure

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM137

21 January 2018

Inhibition of a signaling pathway in cardiac muscle cells by active mitogen-activated protein kinase kinase

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM137

21 January 2018

p38 Mitogen-activated protein kinase mediates a negative inotropic effect in cardiac myocytes

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM137

21 January 2018

Pharmacological inhibitors of MAPK pathways.

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM137

21 January 2018

Targeting the JNK MAPK cascade for inhibition: basic science and therapeutic potential.

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM137

21 January 2018

ErmineJ: tool for functional analysis of gene expression data sets

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM137

21 January 2018

The nuclear lamina is a meshwork of intermediate-type filaments

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM137

21 January 2018

Identifiers

10.1093/HMG/DDM137

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34580311&oldid=1593639675"